LCN2 and chronic kidney disease: Bolignano et al. (22), studying a cohort of 96 patients with CKD from various etiologies, reported serum and urinary NGAL to be inversely correlated with eGFR; both markers predicted progression of renal impairment after a median follow-up of 18.5 months.